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Abstract
Background: Over 1.2 million people are blind from trachomatous trichiasis (TT). Lid rotation surgery is the mainstay of
treatment, but recurrence rates can be high. We investigated the outcomes (recurrence rates and other complications) of
posterior lamellar tarsal rotation (PLTR) surgery, one of the two most widely practised TT procedures in endemic settings.
Methodology/Principal Findings: We conducted a two-year follow-up study of 1300 participants who had PLTR surgery,
conducted by one of five TT nurse surgeons. None had previously undergone TT surgery. All participants received a detailed
trachoma eye examination at baseline and 6, 12, 18 and 24 months post-operatively. The study investigated the recurrence
rates, other complications and factors associated with recurrence. Recurrence occurred in 207/635 (32.6%) and 108/641
(16.9%) of participants with pre-operative major (.5 trichiatic lashes) and minor (,5 lashes) TT respectively. Of the 315
recurrences, 42/315 (3.3% overall) had .5 lashes (major recurrence). Recurrence was greatest in the first six months after
surgery: 172 cases (55%) occurring in this period. Recurrence was associated with major TT pre-operatively (OR 2.39, 95% CI
1.83–3.11), pre-operative entropic lashes compared to misdirected/metaplastic lashes (OR 1.99, 95% CI 1.23–3.20), age over
40 years (OR 1.59, 95% CI 1.14–2.20) and specific surgeons (surgeon recurrence risk range: 18%–53%). Granuloma occurred
in 69 (5.7%) and notching in 156 (13.0%).
Conclusions/Significance: Risk of recurrence is high despite high volume, highly trained surgeons. However, the vast
majority are minor recurrences, which may not have significant corneal or visual consequences. Inter-surgeon variation in
recurrence is concerning; surgical technique, training and immediate post-operative lid position require further
investigation.
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Introduction
Blindness from trachoma is the end result of progressive scarring
of the conjunctiva driven by Chlamydia trachomatis. The major risk
factor of blinding corneal opacification (CO) is trichiasis (TT), the
in turning of the eyelashes. TT traumatises the delicate epithelium
of the cornea, rendering it vulnerable to secondary infection. TT
encompasses a range of eyelid and eyelash abnormalities from a
few peripheral in turned lashes to the entire upper eyelid pulled
inwards by scarring (entropion). TT can also occur without
entropion, from metaplastic or misdirected lashes [1]. Recent
global estimate suggested that in 2008 there were 8.2 million
people living with trichiasis. Surgical treatment for TT is a key
component of the SAFE strategy for trachoma control, directly
reducing the risk of blindness [2].
Several different surgical procedures have been used to correct
upper lid TT, some of which have been compared in randomized
trials [3–6]. The technique of Bilamellar Tarsal Rotation (BLTR)
has the lowest recurrence risk. However, the widely used Posterior
Lamellar Tarsal Rotation (PLTR or ‘Trabut’ procedure) was not
included in these comparisons. The World Health Organisation
(WHO) advocates either BLTR or PLTR surgery for TT [7]. Both
procedures involve a horizontal tarsotomy combined with everting
sutures to rotate the inferior portion of the upper lid outwards [3].
TT surgery can prevent or reduce progression of corneal
opacity, improve vision and relieve pain [6,8,9]. However, surgical
outcomes are variable. Most studies of post-operative TT
recurrence reports rates of 20%–40% at one-year, ranging from
7.4% at one year to 62% at three years [5,6,8,10–22]. Recurrence
is generally subdivided into early (before six months) and late (after
six months). Early recurrence is probably attributable to a number
of factors including the severity of the preoperative disease, the
type and quality of the surgery, and post-operative wound healing
events [8,23,24]. Substantial inter-surgeon variation of TT
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recurrence rates has been reported [8,23]. After six months there is
a steady accumulation of recurrence that probably results from
progressive scarring disease [8,22].
Serious surgical complications are rare in TT surgery.
However, complications such as granuloma and lid contour
abnormalities (notching) occur relatively frequently [23]. Gran-
ulomas are pedunculated masses of inflammatory tissue ranging
in size from a few millimetres to over a centimetre. Larger
granulomas can obscure the visual axis, and all except the
smallest require surgical removal. The reported frequency of
granulomas ranges from 0% to 14% [6,10,11,16,23,25–28]. Lid
notching, a focal overcorrection of the lid caused by irregular
suture tension or an irregular tarsal incision is cosmetically
unsatisfactory and may be associated with lagophthalmos,
putting the cornea at risk [29].
During the course of two recently reported randomised
controlled trials conducted in Ethiopia we recruited 1300
individuals with the full spectrum of TT type and severity, who
received PLTR surgery with silk sutures, and were followed up for
two year [30,31]. This represents the largest data set to date on the
results of PLTR surgery (recurrence risks, vision and other
outcomes), and provides an opportunity to investigate outcomes in
relation to the type and position of the trichiatic lashes.
Methods
Ethical approval
The National Health Research Ethics Review Committee of the
Ethiopian Ministry of Science and Technology, the London
School of Hygiene & Tropical Medicine Ethics Committee and
the Emory University Institutional Review Board approved this
study. Informed consent was taken at the time of enrolment. The
research adhered to the tenets of The Declaration of Helsinki. All
participants gave written informed consent to take part in the
study.
Study design and participants
Two previously reported randomised controlled trials of the
management of TT were conducted in Ethiopia from 2008 to
2010 [30,31]. Each trial recruited 1300 individuals aged 18 years
or older with previously unoperated TT: in each trial one arm
comprised participants undergoing TT surgery with silk sutures.
For the purpose of these studies, TT was defined as one or more
lashes touching the eye or clear evidence of epilation (broken/re-
growing lashes), without another obvious cause for the trichiasis,
such as trauma, malignancy, involutional changes or severe
blepharitis. Exclusion criteria were previous eyelid surgery and
self-reported pregnancy.
Participants presented during TT surgical treatment campaigns
in rural villages in the West Gojjam Zone, Amhara Regional State,
which were advertised in local markets, churches and schools.
Additionally, health extension workers from every sub-district
(kebele) across West Gojjam were trained to recognize trichiasis.
They visited each village in their kebele to identify potential
participants.
In the first trial, individuals with major TT (.5 lashes touching
the eye) were randomly allocated to PLTR surgery with either silk
or polyglactan (vicryl) sutures. In the second trial individuals with
minor TT (,6 lashes touching) were randomly allocated to either
PLTR surgery with silk sutures or repeated epilation. In
individuals with bilateral TT, one eye was randomly designated
(sequentially selected from a blocked randomly generated list of
right and left eyes) as the study eye and included in the analysis,
although both eyes were treated. In both trials, participants were
allocated to surgeons sequentially. Surgeons were not permitted to
select specific participants and participants were not allocated
according to severity.
The group described in this report is comprised of all the
individuals who were randomly allocated to the PLTR with silk
suture arms of the two studies. They represent the full spectrum of
TT disease (both major and minor TT) and received exactly the
same surgical intervention performed by the same group of
surgeons.
Clinical assessment
Participants were examined immediately before surgery and
again at 6, 12, 18 and 24 months. The methods used have been
described in detail [30,31]. Briefly, LogMAR visual acuity was
measured in each eye. Participants’ weight and height were
measured in order to calculate the body mass index (BMI). Both
eyes were examined for signs of trachoma using 2.56magnifica-
tion loupes and a bright torch. Baseline, one-year and two-year
examinations were by a single ophthalmologist (SNR) and the six
and 18-month examinations were by a single ophthalmic nurse
(EH). The examiners were standardised to each other. Lashes
touching the eye were counted (‘lash burden’) and sub-divided into
the part of the eye contacted when looking straight ahead (corneal
or peripheral (lateral or medial conjunctiva) and subdivided by the
type of trichiatic lash (entropic, misdirected or metaplastic).
Clinical evidence of epilation was defined as the presence of
broken or newly growing lashes, or areas of absent lashes. In the
absence of epilation, eyes with,6 trichiatic lashes were designated
as minor TT and those with .5 lashes as major TT. In the
presence of epilation, a clinical judgement was made of the
number of epilated lashes, by assessing regrowing lash stubs that
were pointing towards the globe; if the total trichiatic lashes+e-
pilated lashes was ,6, the lid was designated as having minor TT
and .5 as major TT. Upper lid entropion was graded using a
previously described system [1]. Corneal scarring was classified
based on a modified WHO FPC grading system [32,33]. Corneal
opacity was graded in the field and with high-resolution digital
photographs (Nikon D300, Nikon 105 mm macro lens). The eyelid
was everted and the location of the muco-cutaneous junction
(MCJ) graded [1]. Following surgery the presence/absence of
Author Summary
Trachoma is the most common infectious cause of
blindness worldwide. It causes trichiasis (inturning of the
eyelashes to touch the eye), which can cause visual loss.
Trachomatous trichiasis (TT) affects over eight million
people, 1.2 of whom live in Ethiopia – the most affected
country worldwide. Surgery is the mainstay of treatment
for TT. However, results of surgery in the field are often
very mixed. We investigated the surgical outcomes of one
of the two most widely used surgical techniques (posterior
lamellar rotation), in 1300 individuals in the Amhara
Region of Ethiopia. We found that recurrence occurred
frequently: 315/1276 (24.7%) participants. However, recur-
rence was rarely severe (greater than 5 lashes): 42
participants (3.3%). Recurrence occurred much more
frequently in participants who had severe pre-operative
disease and with specific surgeons. The high recurrence
rates and inter-surgeon variation is concerning. Further
research will be required to investigate factors such as
surgical technique, surgeon training and immediate post-
operative lid position, in order to improve surgical
outcomes.
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Table 1. Demographic and pre-operative clinical characteristics of participants, sub-divided by major and minor trichiasis.
Minor TT (,6 lashes) Major TT (.5 lashes)
Eyes 650 650
Sex (female) 448 (68.9%) 508 (78.2%)
Age
18–30 69 (10.6%) 48 (7.4%)
30–39 113 (17.4%) 123 (18.9%)
40–49 156 (24.0%) 186 (28.6%)
50–59 160 (24.6%) 167 (25.7%)
60–69 112 (17.2%) 93 (14.3%)
70+ 40 (6.2%) 33 (5.1%)
mean (sd, 95% C.I.) 49.9 (14.4, 48.8–51.0) 49.7 (12.9, 48.7–50.7)
Illiterate 581 (89.4%) 617 (94.9%)
BMI, mean (sd, 5% CI) 19.9 (2.3, 19.7–20.1) 20.1 (2.5, 19.9–20.3)
Right eye* 319 (49.1%) 321 (49.4%)
Best corrected logMAR VA in study eye
20.2–0.3 243 (37.7%) 193 (30.0%)
0.3–0.7 261 (40.5%) 248 (38.5%)
0.7–1.1 83 (12.9%) 104 (16.2%)
1.1–2.0 19 (2.9%) 29 (4.5%)
CF/HM/PL 30 (4.6%) 62 (9.6%)
NPL 9 (1.4%) 8 (1.2%)
Not measurable{ 5 6
Entropion grade
0 276 (42.5%) 51 (7.9%)
1 258 (39.7%) 159 (24.5%)
2 113 (17.4%) 242 (37.2%)
3 3 (0.5%) 119 (18.3%)
4 0 (0.0%) 79 (12.2%)
Trichiasis (number of lashes) (median: 1)
None - epilating 124 (19.1%) 106* (16.3%)
1–5 526 (80.9%) 253* (38.9%)
6–9 0 (0.0%) 152 (23.4%)
10–19 0 (0.0%) 89 (13.7%)
20+ 0 (0.0%) 50 (7.7%)
Lash location
None – epilating 124 (19.1%) 106 (16.3%)
Corneal +/2 peripheral 462 (71.1%) 524 (80.6%)
Peripheral only 64 (9.9%) 20 (3.1%)
Lash type
None (epilating) 124 (19.1%) 106 (16.3%)
Metaplastic only 299 (46.0%) 206 (31.7%)
Misdirected only 165 (25.4%) 83 (12.8%)
Metaplastic and misdirected 59 (9.1%) 67 (10.3%)
Entropic +/2 aberrant 3 (0.5%) 188 (28.9%)
Lower lid TT
Present 70 (10.8%) 88 (13.5%)
Corneal opacity
None (C0) 345 (53.1%) 187 (28.8%)
Peripheral (C1) 168 (25.9%) 181 (27.9%)
Off centre faint (C2a) 76 (11.7%) 147 (22.6%)
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notching and granuloma were noted. Notching was defined as
central overcorrection of the lid such as to cause a clear deviation
in contour of the lid margin. This would correspond to either
moderate or severe lid contour abnormalities in a recently
published grading system [34].
Interventions
Surgery was performed under local anaesthesia using the
technique previously described [30,31]. Post-operatively, the
operated eye was padded for a day and then tetracycline eye
ointment was self-administered twice a day for two weeks. Five
nurses, who had previously been trained in and were regularly
performing PLTR surgery, performed the surgery. They were
selected as the best surgeons from a larger group of 10, during a
two-day standardisation workshop. The PLTR techniques of the
five nurses were carefully observed and standardised to ensure
that all performed the operation in the same way. The intra-
operative quality of surgery was periodically reviewed during
the course of the trials. Participants were seen at 7–10 days post-
operatively, at which point silk sutures were removed. The
presence of trichiasis and other complications were noted and
treated as needed. Any individual who had five or more lashes
at any follow-up examination was offered repeat surgery to be
performed by a senior surgeon, within a few weeks of the follow-
up assessment. Individuals in whom other ophthalmic pathology
(e.g. cataract) was detected were referred to the regional
ophthalmic services.
Outcome measures
The primary outcome measure was trichiasis recurrence defined
as either (1) one or more eyelashes touching the eye or (2) clinical
evidence of epilation. Secondary outcome measures were surgical
complications, entropion and conjunctivalisation.
Statistical methods
Data were double entered into an Access (Microsoft) database
and transferred to Stata 11 (StataCorp, College Station, TX). For
participants who had bilateral surgery only the randomly
designated ‘study eye’ was included in the analysis. The
cumulative incidence of failure in each six-month block of
follow-up was calculated using the Kaplan-Meier method. The
associations of binary outcomes with exposures were assessed using
logistic regression to estimate odds ratios (OR) and 95%
confidence intervals (CI). Variables associated with the outcome
on univariate analyses (p,0.2) were retained in the multivariable
model. The p-values for the association between categorical
variables and specific outcomes were calculated using likelihood
ratios. For visual acuities of counting fingers or less, logMAR
values were attributed: counting fingers: 2.0, hand movements:
2.5, perception of light: 3.0, no perception of light: 3.5.
Results
We recruited 1300 individuals with previously unoperated
trichiasis in at least one eye. No individuals refused participation.
Recruitment took place between March and July 2008. The
Table 1. Cont.
Minor TT (,6 lashes) Major TT (.5 lashes)
Eyes 650 650
Off centre dense (C2b) 9 (1.4%) 26 (4.0%)
Central faint (C2c) 30 (4.6%) 63 (9.7%)
Central dense (C2d) 11 (1.7%) 18 (2.8%)
Total central dense (C3) 10 (1.5%) 22 (3.4%)
Phthisis (C4) 1 (0.2%) 6 (0.9%)
Papillary inflammation
None (P0) 52 (8.0%) 52 (8.0%)
Mild (P1) 248 (38.2%) 183 (28.2%)
Moderate (P2) 297 (45.7%) 312 (48.1%)
Severe (P3) 53 (8.2%) 102 (15.7%)
Conjunctival scarring
None (C0) 3 (0.5%) 0 (0.0%)
Mild (C1) 60 (9.2%) 18 (2.8%)
Moderate (C2) 508 (78.2%) 400 (61.6%)
Severe (C3) 79 (12.2%) 231 (35.6%)
Conjunctivalisation Grade
0 7 (1.1%) 2 (0.3%)
1 18 (2.8%) 5 (0.8%)
2 165 (25.4%) 96 (14.8%)
3 460 (70.8%) 545 (84.1%)
Lagophthalmos 10 (1.5%) 20 (3.1%)
*Despite having less than 5 lashes actually touching the globe at the time of examination, these individuals had clinical evidence of epilation of trichiatic lashes, such
that the total of trichiatic lashes would have been greater than 5 had they not epilated.
{Patient unable to co-operate with visual acuity measurement.
doi:10.1371/journal.pntd.0002392.t001
The Outcomes of Trachomatous Trichiasis Surgery
PLOS Neglected Tropical Diseases | www.plosntds.org 4 August 2013 | Volume 7 | Issue 8 | e2392
follow-up assessments were conducted at the following times: 6-
month, August to December 2008; 12-month, February to July
2009; 18-months, August to December 2009; 24-months, January
2010 to May 2010. The final follow-up was conducted two months
ahead of schedule because of the Ethiopian general election (May
2010), during which time follow-up would not have been possible.
Almost all individuals (98.1%) were reviewed on at least one
occasion.
Baseline characteristics are shown in Table 1; 650 eyes had
major TT and 650 had minor TT. All participants were from the
Amhara region of Ethiopia. The logMAR visual acuity was 0.3 (6/
12 Snellen equivalent) or less in 853/1289 (66%) individuals it was
possible to test. Of those with major TT, 359 had less than five
lashes, but had evidence of epilation consistent with the eye having
more than five trichiatic lashes. The majority of the participants
were female (78.2% of those with major TT, 68.9% of those with
minor TT: p= 0.005). Corneal opacity was present in 768 (59.9%)
individuals of whom 419 (32% of all study eyes) had opacity within
the central 4 mm of the cornea.
Recurrent trichiasis
Overall, recurrence occurred in 315/1276 (24.7%) study eyes.
Recurrence was more frequent in participants with pre-operative
major TT (32.6%) compared to minor TT (16.9%): OR 2.39,
95%CI 1.83–3.11, p,0.005 (Figure 1 and Table 2). This
association was found at each follow-up (Table 2). Within both
TT groups, the risk of recurrence was much higher during the first
six-month period compared to all subsequent periods (p,0.0001;
Figure 1 and Table 2), with 58.0% and 48.1% of recurrences
accruing during this initial period in major TT and minor TT
participants, respectively. Thirty-eight participants had recurrence
at the 6 months follow-up, but not at any subsequent timepoint, of
whom ten had repeat TT surgery.
Overall, there was a significant reduction in mean lash burden
between baseline (4.66 lashes) and 24 months (0.29 lashes; t-test
p,0.0005) (Table 2). Amongst people with recurrence who were
examined at 24 months, 14/198 (7.1%) of those with baseline
major TT had more trichiasis at 24 months compared to baseline,
compared with 2/107 (1.9%) of those with baseline minor TT
(Table 2). There were similar risks of recurrence in right and left
eyes in both groups (Table 2).
Individual surgeon’s recurrence rates ranged from 17.7% to
52.6%. The pre-operative severity of cases operated by the
different surgeons varied to a degree (X2: p= 0.035), as did their
post-operative under-correction rates (X2 = 0.003) (Table 3). Their
risk of recurrence was not affected by the variation in case mix
(Table 4). There was no significant difference between the
recurrence rate in the first 20 surgeries conducted by each
surgeon (32/100, 32%) and the last 20 surgeries (29/100, 29%,
p= 0.42).
Multivariable logistic regression modelling identified increased
baseline TT severity, the presence of entropic lashes (compared
with misdirected or metaplastic lashes without entropion), specific
surgeons (No. 2 and No. 5) and older participant age as
independent risk factors for recurrence (Table 4).
Surgical complications
Early (noted by the 7–10 day suture removal follow-up) and
later (seen at any subsequent follow-up) post-operative complica-
tions and their association with recurrent trichiasis are presented
in Table 5. Over three-quarters (23/30, 77%) of individuals noted
to have trichiasis at the 7–10 day follow-up had recurrent trichiasis
at a subsequent follow-up (OR: 10.3, 95% C.I.: 4.33–24.23,
p,0.001) (Table 6). Post-operative granuloma (OR: 0.39, 95%
C.I.: 0.19–0.83, p= 0.014) and notching (OR: 0.44, 95% C.I.:
0.28–0.72, p= 0.001) were both significantly associated with lower
recurrence rates (Table 6).
Univariate and multivariable associations for developing a
granuloma and lid notching are shown in Tables 7. Surgeons
(No. 1 and No. 4) who had the lowest recurrence rates also had
significantly higher rates of granuloma and notching. There was
no association between granuloma formation and visible suture
fragments being left in the lid (X2: p = 0.495), gender (X2:
p = 0.239) or younger (,41 years) age (X2: p = 0.41)
Entropion and conjunctivalization
Surgery successfully corrected entropion: 1148 (93.5%) partic-
ipants at 12 months and 1126 (92.1%) at two years had no
entropion, compared to 327 (25.2%) at baseline (Table 8). Surgery
reduced the entropion grade in 886/918 (97%) (Paired t-test:
p,0.0001). Entropion grade worsened in three participants. In the
1213 participants with conjunctivalization of the lid margin at
baseline, an improvement was seen in 699 (58%) (paired t-test:
p,0.0001) and worsening in 29 individuals (Fig. 1a and b).
Discussion
Trichiasis recurred in a quarter of study eyes by two years.
Recurrence severity was very variable, ranging from a single
peripheral metaplastic lash to complete entropion. However, only
13% of recurrences had more than five lashes touching they eye
Figure 1. Conjunctivalisation of the lid margin. 1a: The lid margin
at baseline showing marked conjunctivalisation; the Meibomian gland
orifices are completely surrounded by conjunctival-type surface. 1b: The
lid margin of the same participant at the two-year follow-up; the
conjunctival surface appears to have receded and the Meibomian gland
orifices are surrounded by skin with a normal appearance.
doi:10.1371/journal.pntd.0002392.g001
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and there was a substantial reduction in lash burden. Therefore,
although any recurrence is unsatisfactory, the likely severity of the
recurrence should be considered in a balanced assessment of the
risks and benefits of surgery.
Over half of all recurrences occurred by six months and the risk
decreased significantly for each subsequent six-month period.
Higher rates of early recurrence have been reported previously. In
a study from The Gambia the recurrence at four years was 41%,
over three quarters of which occurred within the first six months
after surgery [22]. In a study from Southern Ethiopia, the
recurrence rate at 6 weeks was 2.3% and at one year was 7.6%
[17]. Taken together, these observations indicate the importance
of understanding and addressing the determinants of early (,6
months) recurrence. A combination of risk factors are likely to be
important: baseline disease severity, choice of procedure, the
surgeon’s ability, and early wound healing responses are likely to
be dominant. Overall, PLTR was effective at correcting entropion,
with only 8% of participants having residual entropion at the end
of the follow-up. Conjunctivalization of the lid margin reversed;
the epithelium with conjunctival appearance recedes and meibo-
mion gland openings become surrounded by macroscopically
normal looking skin, presumably in response to an altered
epithelial environment following entropion correction.
Pre-operative disease severity
Recurrence was twice as frequent in individuals with major TT
pre-operatively. Furthermore, pre-operative entropic trichiasis
(rather than misdirected or metaplastic) was an independent risk
factor for recurrence. More severe pre-operative trichiasis is
consistently a major risk factor for recurrent TT [8,11,15,17–
20,22,35,36]. Such individuals generally have more conjunctival
scarring and may have horizontal or vertical lid shortening. The
lid surgery is technically more challenging as the anterior and
posterior lamellae are more difficult to dissect and post-operatively
Table 2. Risk of trichiasis recurrence and severity, subdivided by baseline severity.
Baseline TT Severity
Minor TT Major TT Total
a) Number of Incident Recurrence Cases at each time-point (months)
6 52/615 (8.5%) 120/587 (20.4%) 172/1202 (14.3%)
12 23/622 (3.7%) 37/612 (6.1%) 60/1234 (4.9%)
18 22/620 (3.6%) 34/622 (5.5%) 56/1242 (4.5%)
24 11/614 (1.8%) 16/619 (2.6%) 27/1233 (2.2%)
Total 108/641* (16.9%) 207/635* (32.6%) 315/1276* (24.7%)
b) Recurrence severity
None 533 (83.2%) 428 (67.4%) 961 (75.3%)
Minor 104 (16.2%) 169 (26.6%) 273 (21.4%)
Major (at 1 or more follow-ups) 4 (0.6%) 38 (6.0%) 42 (3.3%)
Total 641 635 1276
c) Recurrence risks by eye
Right 49/314 (15.6%) 102/316 (32.3%) 151/630 (24.0%)
Left 59/327 (18.0%) 105/319 (32.9%) 164/646 (25.4%)
Total 108 207 315
d) Change in lash burden between baseline and 24 months in participants with recurrence
.5 more lashes at 24 m 0 (0.0%) 2 (1.0%) 2 (0.7%)
1–5 more lashes at 24 m 2 (1.9%) 12 (6.1%) 14 (4.6%)
Same number lashes at 24 m 26 (24.3%) 35 (17.7%) 61 (20.0%)
1–5 fewer lashes at 24 m 79 (73.8%) 66 (33.3%) 145 (47.5%)
6–20 fewer lashes at 24 m 0 (0.0%) 69 (34.9%) 69 (22.6%)
.20 fewer lashes at 24 m 0 (0.0%) 14 (7.1%) 14 (4.6)
Total 107 (100%) 198 (100%) 305 (100%)
e) Recurrence risks by baseline lash type
No lashes (epilating) 11/123 (8.9%) 34/101 (33.7%) 45/224 (20.1%)
Metaplastic lashes only 54/293 (18.4%) 64/200 (32.0%) 118/493 (23.9%)
Misdirected lashes only 27/164 (16.5%) 16/83 (19.3%) 43/247 (17.4%)
Aberrant lashes{ 15/58 (25.9%) 14/65 (21.5%) 29/123 (23.6%)
Entropic +/2 aberrant lashes 1/3 (33.3%) 79/186 (42.5%) 80/189 (42.3%)
*Number of individuals seen on at least one follow-up.
{Aberrant lashes = either metaplastic or misdirected.
(a) Incident recurrence at each time-point. (b) Severity of the recurrence. (c) Recurrence rates by eye. (d) Change in the number of lashes between baseline and 24
months. (e) Recurrence by type of lash at baseline.
doi:10.1371/journal.pntd.0002392.t002
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there may be strong contractile forces pulling the lid back to an
entropic position. These cases, who are at higher risk of sight
threatening disease, should be treated by more experienced surgeons
and have enhanced follow-up to detect recurrence. Interestingly,
metaplastic lashes, even in the absence of entropion, appear to be
‘cured’ by surgery. It is unclear whether they cease to grow, or
whether they are simply rotated far enough away from the globe.
Surgical procedure
In our study only the PLTR procedure was used and gave
recurrence rates in the middle of the reported range for this
procedure: 12% to 55%, with reported follow-up periods of
between 3 months and four years [8,10,20–22,26,37,38]. One
randomised trial has compared the PLTR and BLTR procedures
and found similar outcomes [10]. However, ophthalmologists
Table 3. Baseline severity of cases operated (case mix), under-correction and overall trichiasis recurrence rates by surgeon.
Surgeon ID Total
1 2 3 4 5
Baseline TT Severity
Minor 186 (49.5%) 149 (52.7%) 167 (55.1%) 118 (45.4%) 30 (38.5%) 650 (50%)
Major 190 (50.5%) 134 (47.4%) 136 (44.9%) 142 (54.6%) 48 (61.5%) 650 (50%)
Total 376 283 303 260 78 1300
TT at 7–10 days post-operatively*
11 (2.9%) 9 (3.2%) 5 (1.7%) 7 (2.7%) 8 (10.3%) 40 (3.1%)
Recurrence during the 24 months of follow-up1
Yes 75 (20.3%) 88 (32.0%) 67 (22.3%) 45 (17.7%) 40 (52.6%) 315 (24.7%)
Total Seen 370 275 301 254 76 1276
*Denominator: total number of patients operated by that surgeon.
1Denominator: participants seen on at least one follow up occasion.
doi:10.1371/journal.pntd.0002392.t003
Table 4. Univariable analysis and multivariable logistic regression model for baseline associations with any TT recurrence.
Variable Univariable Analysis Multivariable Analysis
OR 95% CI p Value OR 95% CI p Value
Female 1.11 0.83–1.49 0.47
Age.40 1.65 1.21–2.24 0.002 1.59 1.14–2.20 0.006
Literate 0.79 0.48–1.29 0.35
BMI,18 0.70 0.51–0.95 0.024 0.79 0.56–1.09 0.15
Major TT at baseline 2.39 1.83–3.11 ,0.001 1.93 1.43–2.60 ,0.001
Eye (Right) 1.08 0.84–1.39 0.56
Baseline entropion severity* 1.35 1.21–1.51 ,0.001
Surgeon{ ,0.001 ,0.001
1 1.18 0.78–1.78 1.23 0.81–1.88
2 2.19 1.45–3.29 2.46 1.60–3.77
3 1.33 0.87–2.03 1.49 0.9762.30
5 5.16 2.97–8.98 5.18 2.90–9.26
Baseline lash type` ,0.001 ,0.001
Metaplastic only 1.25 0.85–1.84 1.27 0.85–1.90
Misdirected only 0.84 0.53–1.33 0.89 0.55–1.43
Metaplastic and misdirected 1.23 0.72–2.08 1.10 0.63–1.92
Entropic +/2 aberrant 2.92 1.89–4.51 1.99 1.23–3.20
Purulent discharge at baseline 1.86 1.17–2.95 0.009 1.21 0.73–2.02 0.46
Mucus discharge at baseline 1.39 0.63–3.06 0.42
Baseline Inflammation (P2/P3) 1.37 1.06–1.79 0.018 1.23 0.93–1.63 0.15
*Entropion treated as a linear variable (LR test for linearity: p = 0.07).
Entropion dropped from multivariable model as strongly linked to baseline lash type.
{Compared to surgeon 4 who had the lowest recurrence rate. Likelihood ratio used to calculate p value for association between surgeon and recurrent TT.
`Compared to group with all trichiatic lashes epilated. Likelihood ratio used to calculate p value for association between lash type and recurrent TT.
doi:10.1371/journal.pntd.0002392.t004
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performed all the surgery, follow-up was only three months and
sample size insufficient to address the question. The range of
outcomes in these different studies suggests that a comparative trial
of PLTR and BLTR is required under more representative
operational conditions to determine if one procedure is superior,
particularly for more severe cases.
Inter-surgeon variation
The surgeons in this study were selected for their surgical ability
and given additional training. Their technique was intermittently
observed. Nevertheless, two surgeons had significantly higher
recurrence rates than the best performing surgeon. Surgeon No. 5,
who had the highest recurrence rate, did operate on a higher
proportion of major TT cases than the other surgeons, but
remained an independent risk factor for recurrence after adjusting
for baseline TT severity.
Inter-surgeon variability has previously been highlighted as a
concern in trachoma surgery with one study finding recurrence
rates ranging from 0–83% between surgeons [8]. Several factors
may contribute to variable outcomes. Firstly, surgical training
varies in quality and number of cases performed [39]. Secondly,
supervision and refresher training is often sporadic and of variable
quality and content, with many surgeons operating entirely
independently [39,40]. Thirdly, surgical volume may be low
which may lead to loss of surgical skills. In cataract surgery, for
example, higher volume is associated with better outcomes [41].
The WHO advises that a minimum of 10 TT procedures per
month should be conducted [7]. Studies from Ethiopia and
Tanzania found few high volume surgeons, with the vast majority
of TT surgeons perform few cases [39,42]. In our study surgeon 5
did perform less procedures than the other surgeons as she was
dismissed for disciplinary matters mid-way through the trial.
However, she still conducted over 150 procedures during the trials
from which this study emanates, so low surgical volume is unlikely
to explain the variation. Finally, despite attempts to standardise,
subtle residual variation in technical ability and technique
probably remain. For example, short incisions have been
associated with increased recurrence following BLTR surgery
(crude OR: 3.58, 95% C.I.: 1.39–9.23) [23]. The immediate post-
operative lid position warrants further investigation: if this is
Table 5. Frequency and risk of post-operative complications, stratified by baseline disease severity. Trichiasis recurrence rates in
eyes with the specific complication.
Baseline TT Severity
Minor TT Major TT Total
Intra-operative
Bleeding 11 (1.7%) 6 (0.9%) 17 (1.3%)
Early (by 7–10 days)
TT recurrence at 7–10 days 5 (0.8%) 24 (3.8%) 29 (2.3%)
Overcorrection 2 (0.3%) 4 (0.6%) 6 (0.5%)
Infection/erythematous swelling/conjunctivitis 3 (0.5%) 6 (0.9%) 10 (0.8%)
Infection & undercorrection 1 (0.2%) 0 (0.0%) 1 (0.1%)
Bleeding 3 (0.5%) 1 (0.2%) 4 (0.3%)
Late (6,12,18 or 24 month)
Granuloma 18 (2.9%) 51 (8.7%) 69 (5.7%)
Notching 86 (14.0%) 70 (11.9%) 156 (13.0%)
Residual suture fragments 7 (1.1%) 15 (2.6%) 22 (1.8%)
Lid abscess 1 (0.2%) 0 (0.0%) 1 (0.1%)
doi:10.1371/journal.pntd.0002392.t005
Table 6. Univariable and multivariable associations between recurrent TT and intra- and post-operative complications.
Variable Univariable Analysis Multivariable Analysis
OR 95% CI p Value OR 95% CI p Value
Intra-operative haemorrhage 0.65 0.18–2.27 0.50
Trichiasis at 7–10 days 10.25 4.33–24.23 ,0.001 10.44 4.20–25.95 ,0.001
7–10 day overcorrection 1.63 0.30–8.95 0.57
7–10 day infection/swelling/conjunctivitis 1.63 0.41–6.56 0.49
Granuloma 0.39 0.19–0.83 0.014 0.31 0.13–0.74 0.008
Notching 0.44 0.28–0.72 0.001 0.52 0.32–0.85 0.009
Residual suture fragment(s) 1.47 0.59–3.63 0.409
Inflammation (P2/P3) at 12 months 1.70 1.14–2.54 0.01 1.64 1.06–2.53 0.027
doi:10.1371/journal.pntd.0002392.t006
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Table 7. Univariable and multivariable intra and post-operative associations for granuloma and notching.
Variable Granuloma Notching
Univariable analysis Multivariable analysis Univariable analysis Multivariable analysis
OR 95% CI p Value OR 95% CI p Value OR 95% CI p Value OR 95% CIp Value
Recurrence 0.39 0.19–0.83 0.014 0.33 0.15–0.71 0.005 0.39 0.19–0.83 0.014 0.49 0.30–
0.81
0.005
.5 lashes at baseline 3.16 1.82–5.47 ,0.001 4.07 2.16–7.67,0.001 0.83 0.59–1.17 0.29
Baseline entropion
severity
1.17 0.95–1.44 0.15 0.86 0.66–1.11 0.25 0.90 0.77–1.05 0.18 0.96 0.82–
1.13
0.35
Surgeon* 0.0267 ,0.001 ,0.001 0.002
1 2.23 1.06–4.71 0.62 0.30–1.27 2.20 1.28–3.79 2.02 1.17–
3.49
2 1.31 0.56–3.09 0.44 0.20–0.93 1.0 n/a 1.0
3 1.0 n/a 1.0 n/a 1.76 0.99–3.13 1.62 0.91–
2.91
4 2.42 1.11–5.27 0.97 0.52–1.81 2.71 1.55–4.74 2.47 1.40–
4.35
5 0.41 0.05–3.29 0.18 0.023–
1.39
0.37 0.084–
1.63
0.41 0.09–
1.83
Inflammation at
baseline (P2/P3)
2.14 1.29–3.57 0.003 2.23 1.33–3.78 0.003 0.67 0.47–0.94 0.022 0.75 0.53–
1.07
Female 0.73 0.44–1.23 0.24 0.79 0.55–1.14 0.21
Age.40 yrs 0.80 0.47–1.35 0.41 2.06 1.32–3.20 0.001 1.99 1.26–
3.12
0.003
BMI.18 1.44 0.72–2.86 0.30 0.65 0.44–0.96 0.032 0.65 0.43–
0.97
0.034
*Surgeon and granuloma association: other surgeons compared to surgeon 3. Surgeon 5 had the lowest granuloma rate but performed substantially fewer procedures
than the other surgeons. Surgeon 3 had the second lowest rate.
Notching and granuloma association: other surgeons compared to surgeon 2. Surgeon 5 had the lowest notching rate, but performed substantially fewer procedures
than the other surgeons. Surgeon 2 had the second lowest rate.
doi:10.1371/journal.pntd.0002392.t007
Table 8. The effect of surgery on clinical characteristics at 12 and 24 months subdivided by baseline severity.
Baseline 12 months 24 months
Clinical Feature
Minor at
baseline Major at baseline Total
Minor at
baseline
Major at
baseline Total
Eyes 1300 620 608 1228* 613 609 1222*
Entropion grade
0 327 (25.2%) 598 (96.5%) 550 (90.5%) 1148 (93.5%) 588 (95.9%) 538 (88.3%) 1126 (92.1%)
1 417 (32.1%) 19 (3.1%) 34 (5.6%) 53 (4.3%) 18 (2.9%) 44 (7.2%) 62 (5.1%)
2 355 (27.3%) 3 (0.5%) 16 (2.6%) 19 (1.6%) 7 (1.1%) 22 (3.6%) 29 (2.4%)
3 122 (9.4%) 0 (0.0%) 6 (1.0%) 6 (0.5%) 0 (0.0%) 4 (0.7%) 4 (0.3%)
4 79 (6.1%) 0 (0.0%) 2 (0.3%) 2 (0.2%) 0 (0.0%) 1 (0.2%) 1 (0.1%)
Conjunctivalisation Grade
0 9 (0.7%) 115 (18.6%) 84 (13.8%) 199 (16.2%) 74 (12.1%) 55 (9.0%) 129 (10.6%)
1 23 (1.8%) 88 (14.2%) 88 (14.5%) 176 (14.3%) 63 (10.3%) 68 (11.2%) 131 (10.7%)
2 261 (20.1%) 258 (41.6%) 249 (40.9%) 507 (41.3%) 309 (50.4%) 274 (45.0%) 583 (47.7%)
3 1005 (77.4%) 159 (25.7%) 187 (13.8%) 346 (28.2%) 167 (27.2%) 212 (34.8%) 379 (31.1%)
*Total number of participants seen at 12 and 24 months. On occasion, a specific part of the examination was not possible for a particular participant; therefore the total
for each examination characteristic is not always identical to these total figures.
doi:10.1371/journal.pntd.0002392.t008
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predictive of outcome, immediate revision could be undertaken. In
programmatic settings, if individual surgeons are underperforming
this needs to be addressed. Ideally, they would receive refresher
training and be reassessed. Unfortunately, TT surgical audit is
rarely conducted, so poor performance is probably frequently
missed.
Notching
Notching is focal external rotation or irregularity of part of the
lid usually caused by excessive suture tension. Some authors
include notching within a broader category of ‘lid contour
abnormalities’ [11]. Large notches may cause lagophthalmos
and disruption of the tear film, leading to corneal exposure.
Notching can be cosmetically unsightly, in contrast to general
overcorrection which is less noticeable. Other studies have
reported notches in 6–30% for PLTR surgery and 0–14% in
BLTR surgery [11,21,23,27,37]. The association between notch-
ing and reduced recurrence is not surprising, as notching usually
reflects a degree of overcorrection. Notching occurred more
frequently in older and less well nourished people (lower BMI),
which may reflect age and nutrition-related reduction in tarsal
plate rigidity, leading to a more pliable eyelid.
Granuloma
Granulomas usually develop at the incision site within weeks of
surgery. They require excision when they are large. In ophthalmic
surgery they have been described following tarsal rotation and
chalazion surgery and found to be associated with residual suture
fragments, male gender and younger age [23,43]. Here we report
an association between granulomas and a lower recurrence rate
and increased baseline papillary inflammation. Granulomas do
not usually develop following surgery that tightly closes the incision
site. In tarsal rotation surgery, the everting sutures hold the lid in
an out-turned position, which may slightly part the edges of the
incision from where granulomas develop. With greater external
rotation, the posterior incision is less well opposed, leading to more
granulation tissue formation. Granulomas may therefore be an
inevitable consequence of tarsal rotation surgery with a good
degree of eversion.
This study has a number of limitations that potentially constrain
the generalisation of the conclusions. It is possible that the results
are better than those achieved under routine operational
conditions. The five surgeons were selected for their technical
skill, received additional training and supervision and performed
relatively large volume surgery. They are, therefore, not truly
representative of many ‘field’ TT surgeons, who typically perform
few cases, have limited training and supervision [39,42]. Partic-
ipants were not randomly assigned to a surgeon, however, the risk
of selection bias was low, as participants were allocated on a ‘‘first-
come-first-served’’ as surgeons became available. Finally, only one
operation type, the PLTR, was used for all cases.
Set against these limitations, this study has a number of
strengths. Firstly, we report the results of a large number of
operations performed in a standardised manner. Secondly, follow-
up rates are high despite the inaccessibility of many participants;
reducing follow-up bias. Finally, participants were representative
of the spectrum of TT disease in the wider population of TT
patients in Ethiopia, which remains the country with the highest
prevalence of TT in the world.
Recurrence rates were comparable to previous studies. Baseline
disease severity and inter-surgeon variation are major determi-
nants of recurrent disease. However, PLTR surgery successfully
corrected most entropion and much of the recurrence was minor,
which may not represent a significant risk for most patients. The
inter-surgeon variation in recurrence rates is concerning. Further
research is needed to ascertain whether recurrence can be
predicted immediately after surgery, and whether it can be
ameliorated.
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